This site is for healthcare professionals. If you are a member of the public or a patient then please visit our Colonoscopy site.
Download a handy printable guide to preparing and taking PLENVU®
Download two-day (evening/morning) dosing guide
Download dosing schedules to give to your patients
Download two-day (evening/morning) dosing schedule
Adverse events should be reported to your regulatory agency. Adverse events should also be reported to either your local distributor, Norgine Limited, Norgine House, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, United Kingdom or by emailing GPharmacoVigilance@norgine.com.
Registered number 30127007. Copyright Norgine 2021.
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam. The Netherlands.
PLENVU, MOVIPREP, NORGINE and the sail logo are registered trademarks of the Norgine group of companies.
Images of people are for illustrative purposes only. Any persons depicted are models and do not use or personally endorse PLENVU®.
Please confirm which site you would like to proceed with below:
GL-GE-PLV-2100007
Led by Prof Alessandro Repici, world‑renowned experts discuss:
This webinar is hosted in partnership with ESGE.
This webinar is part of the ESGE Satellite webinar series.
GL-GE-PLV-2100042. Date of preparation: April 2021.
This symposium is funded and organised by Norgine.
NORGINE and the sail logo are registered trademarks of the Norgine group of companies.
